Reported 3,104,361 shares, down 520,252 (14.4%) from the prior quarter.
Reported value -4.3%; share count -14.4% vs. the prior quarter.
Reported position value by quarter
Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.
| Date | Holding Value |
|---|---|
| 2023-12-31 | 9873573 |
| 2024-03-31 | 19267784 |
| 2024-06-30 | 28037580 |
| 2024-09-30 | 32751132 |
| 2024-12-31 | 41226580 |
| 2025-03-31 | 36572345 |
| 2025-06-30 | 34986148 |
| 2025-09-30 | 0 |
Quarterly position history
How this manager's reported quarter-end position changed over time.
| Quarter | Activity | Shares | Change | % of reported 13F | Reported value | Filed | Source filing |
|---|---|---|---|---|---|---|---|
| Q3 2025 | Reduced | 0 | -3,104,361 (-100.0%) | 0 | $0 | 2025-11-13 | |
| Q2 2025 | Reduced | 3,104,361 | -520,252 (-14.4%) | 3.13% | $34,986,148 | 2025-08-13 | |
| Q1 2025 | Added | 3,624,613 | +139,695 (4.0%) | 3.83% | $36,572,345 | 2025-05-14 | |
| Q4 2024 | Added | 3,484,918 | +646,865 (22.8%) | 3.49% | $41,226,580 | 2025-02-12 | |
| Q3 2024 | Added | 2,838,053 | +185,491 (7.0%) | 3.61% | $32,751,132 | 2024-11-13 | |
| Q2 2024 | Added | 2,652,562 | +824,499 (45.1%) | 2.36% | $28,037,580 | 2024-08-13 | |
| Q1 2024 | Added | 1,828,063 | +948,849 (107.9%) | 3.56% | $19,267,784 | 2024-05-14 | |
| Q4 2023 | New | 879,214 | +879,214 (0.0%) | 1.66% | $9,873,573 | 2024-02-08 |
Who else reported the position
374 managers reported ROIVANT SCIENCES LTD for Q2 2025.
| Manager | Activity | Shares | Change | % of reported 13F | Reported value | Tenure |
|---|---|---|---|---|---|---|
| SB INVESTMENT ADVISERS UK LTD | Reduced | 59,952,652 | -1,900,066 | 5.36% | $675,666,388 | 15 qtrs |
| FMR LLC | Added | 55,509,281 | +3,842,770 | 0.04% | $625,589,596 | 15 qtrs |
| MORGAN STANLEY | Added | 44,693,966 | +8,767,207 | 0.03% | $503,701,008 | 15 qtrs |
| BlackRock Inc | Reduced | 40,316,307 | -1,343,181 | < 0.01% | $454,364,775 | 4 qtrs |
| VANGUARD GROUP INC | Reduced | 39,326,336 | -1,441,254 | < 0.01% | $443,207,807 | 15 qtrs |
| VIKING GLOBAL INVESTORS LP | Reduced | 34,237,779 | -11,775,973 | 1.12% | $385,859,769 | 15 qtrs |
| QVT Financial LP | Reduced | 29,381,635 | -36,412,144 | 29.5% | $331,131,026 | 15 qtrs |
| Rubric Capital Management LP | Added | 20,370,336 | +2,603,260 | 3.47% | $229,573,687 | 11 qtrs |
| STATE STREET CORPORATION | Added | 19,773,480 | +911,827 | < 0.01% | $222,847,120 | 15 qtrs |
| Patient Square Capital LP | Unchanged | 12,480,000 | 0 | 50.71% | $140,649,600 | 11 qtrs |
Filing details and methodology As reported
- Report period
- June 30, 2025
- Filed
- August 13, 2025
- Filing type
- 13F-HR
- Position type
- SHS
Voting authority reported
- Sole
- 3,104,361
- Shared
- 0
- None
- 0
“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.
Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.